This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
NIAID-RFI-NOT-AI-15-034: Request for Information (RFI): Development of Radiation/Nuclear Medical Countermeasures, Predictive Biomarkers, and Biodosimetry Devices. Due Date May 26, 2015.
Media Availability: NIH-Funded Research Leads to Approval of Drug for Acute Radiation Injury—April 21, 2015
FDA approves Neupogen® for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident
RFP-15-100-SOL-00004: BARDA Chem and Rad/Nuc Animal Model Development. Response date: May 4, 2015.
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated April 29, 2015